title: Polycomb group genes are targets of aberrant DNA methylation in renal cell carcinoma.
abstract: The combined effects of genetic and epigenetic aberrations are well recognized as causal in tumorigenesis. Here, we defined profiles of DNA methylation in primary renal cell carcinomas (RCC) and assessed the association of these profiles with the expression of genes required for the establishment and maintenance of epigenetic marks. A bead-based methylation array platform was used to measure methylation of 1,413 CpG loci in ~800 cancer-associated genes and three methylation classes were derived by unsupervised clustering of tumors using recursively partitioned mixture modeling (RPMM). Quantitative RT-PCR was performed on all tumor samples to determine the expression of DNMT1, DNMT3B, VEZF1 and EZH2. Additionally, methylation at LINE-1 and AluYb8 repetitive elements was measured using bisulfite pyrosequencing. Associations between methylation class and tumor stage (p = 0.05), LINE-1 (p < 0.0001) and AluYb8 (p < 0.0001) methylation, as well as EZH2 expression (p < 0.0001) were noted following univariate analyses. A multinomial logistic regression model controlling for potential confounders revealed that AluYb8 (p < 0.003) methylation and EZH2 expression (p < 0.008) were significantly associated with methylation class membership. Because EZH2 is a member of the Polycomb repressive complex 2 (PRC2), we next analyzed the distribution of Polycomb group (PcG) targets among methylation classes derived by clustering the 1,413 array CpG loci using RPMM. PcG target genes were significantly enriched (p < 0.0001) in methylation classes with greater differential methylation between RCC and non-diseased kidney tissue. This work contributes to our understanding of how repressive marks on DNA and chromatin are dysregulated in carcinogenesis, knowledge that might aid the development of therapies or preventive strategies for human malignancies.
authors: Department of Pathology, Brown University, Providence, RI, USA.
authors: Michele
authors: M
authors: Avissar-Whiting
authors: Devin C
authors: DC
authors: Koestler
authors: E Andres
authors: EA
authors: Houseman
authors: Brock C
authors: BC
authors: Christensen
authors: Karl T
authors: KT
authors: Kelsey
authors: Carmen J
authors: CJ
authors: Marsit
references: Nat Rev Genet. 2002 Jun;3(6):415-28
references: 12042769
references: Biostatistics. 2004 Jul;5(3):329-40
references: 15208198
references: Curr Opin Urol. 2009 Sep;19(5):441-6
references: 19584732
references: Clin Cancer Res. 2009 Sep 15;15(18):5678-87
references: 19755393
references: Nat Genet. 2007 Feb;39(2):237-42
references: 17211412
references: Genes Dev. 2008 Aug 1;22(15):2075-84
references: 18676812
references: J Urol. 2008 Sep;180(3):1126-30
references: 18639284
references: Oncol Rep. 2008 Nov;20(5):1257-63
references: 18949430
references: Genome Res. 2006 Mar;16(3):383-93
references: 16449502
references: PLoS One. 2010 Aug 23;5(8):e12334
references: 20808801
references: Oncogene. 2010 Apr 8;29(14):2104-17
references: 20154727
references: BMC Bioinformatics. 2008 Sep 09;9:365
references: 18782434
references: Eur Urol. 2007 Jun;51(6):1502-10
references: 17408850
references: PLoS Genet. 2009 Aug;5(8):e1000602
references: 19680444
references: Science. 1993 May 28;260(5112):1317-20
references: 8493574
references: Cancer Res. 2009 Aug 1;69(15):6315-21
references: 19638575
references: CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49
references: 19474385
references: J Transl Med. 2009 Oct 26;7:90
references: 19857250
references: Carcinogenesis. 2009 Mar;30(3):416-22
references: 19126652
references: Cancer Res. 2006 Nov 1;66(21):10621-9
references: 17079487
references: Cell. 2006 Apr 21;125(2):301-13
references: 16630818
references: Clin Lab Med. 2005 Jun;25(2):433-64
references: 15848745
references: N Engl J Med. 2008 Mar 13;358(11):1148-59
references: 18337604
references: Genes Dev. 2006 May 1;20(9):1123-36
references: 16618801
references: Carcinogenesis. 2010 Nov;31(11):1972-6
references: 20802236
references: Mol Cancer. 2009 Jun 03;8:31
references: 19493342
references: Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9700-4
references: 7937876
references: Int J Cancer. 2009 Aug 1;125(3):723-9
references: 19437537
references: Int J Oncol. 2010 Dec;37(6):1537-46
references: 21042723
references: PLoS Genet. 2010 Jul 29;6(7):e1001043
references: 20686660
references: Nature. 2006 Feb 16;439(7078):871-4
references: 16357870
references: Nat Genet. 2007 Feb;39(2):232-6
references: 17200670
references: Br J Cancer. 2008 Jan 29;98(2):496-501
references: 18195710
references: Nat Genet. 1994 May;7(1):85-90
references: 7915601
references: Int J Cancer. 2008 Oct 1;123(7):1545-50
references: 18623083
references: Clin Cancer Res. 2010 Mar 1;16(5):1682-9
references: 20179218
references: Genome Res. 2006 Jul;16(7):890-900
references: 16751344
references: J Urol. 2009 Dec;182(6):2920-5
references: 19846140
references: Nature. 2011 Jan 27;469(7331):539-42
references: 21248752